Clinical Oncology
Volume 22, Issue 8 , Pages 636-642 , October 2010

Survey of the Availability and Use of Advanced Radiotherapy Technology in the UK

  • W.P.M. Mayles

      Affiliations

    • Corresponding Author InformationAuthor for correspondence: W.P.M. Mayles, Physics Department, Clatterbridge Centre for Oncology NHS Foundation Trust, Bebington, Wirral, Merseyside CH63 4JY, UK. Tel/Fax: +44-151-604-7391.
  • ,
  • on behalf of the Radiotherapy Development Board

      Affiliations

    • Radiotherapy Development Board: A. Barrett (University of East Anglia, representing the National Radiotherapy Action Group, UK), J. Barrett (Royal Berkshire Hospital, representing the Royal College of Radiologists [RCR], UK), C. Beardmore (representing the Society and College of Radiographers [SCoR], UK), S. Davies (North Middlesex University Hospital, London, UK), S. Hood (lay representative), R. Mackay (Christie NHS Foundation Trust, representing the Institute of Physics in Engineering and Medicine [IPEM], UK), P. Mayles (Clatterbridge Centre for Oncology, representing the National Cancer Research Institute [NCRI], UK), A. Poynter (Ipswich Hospital NHS Trust, representing the Academic Clinical Oncology and Radiobiology Research Network [ACORRN], UK), P. Price (University of Manchester, ACORRN, UK), D. Routsis (Addenbrooke’s Hospital, SCoR, UK), J. Staffurth (Cardiff University, NCRI, UK), S. Thomas (Addenbrooke’s Hospital, IPEM, UK), M. Williams (Addenbrooke’s Hospital, RCR, UK).

Received 22 March 2010 ,Revised 18 May 2010 ,Accepted 23 June 2010.

  • Image Result

    Proportion of radical patients in individual centres receiving (a) forward- and (b) inverse-planned intensity-modulated radiotherapy. The lines indicate the target number based on the views of respond

    Proportion of radical patients in individual centres receiving (a) forward- and (b) inverse-planned intensity-modulated radiotherapy. The lines indicate the target number based on the views of respondents derived from Table 3.

  • Image Result
    Histogram showing the proportion of all centres who considered a particular level of patients should be treated with intensity-modulated radiotherapy. (a) Forward breast planning, (b) prostate plannin

    Histogram showing the proportion of all centres who considered a particular level of patients should be treated with intensity-modulated radiotherapy. (a) Forward breast planning, (b) prostate planning, both forward and inverse, (c) head and neck inverse planning.

PII: S0936-6555(10)00222-0

doi: 10.1016/j.clon.2010.06.014

Clinical Oncology
Volume 22, Issue 8 , Pages 636-642 , October 2010